FindTrial
Sign In

Subanesthetic dose of esketamine alleviates acute postoperative pain of acoustic neuroma

Subanesthetic dose of esketamine alleviates acute postoperative pain of acoustic neuroma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057148
Enrollment
Unknown
Registered
2022-03-01
Start date
2022-03-07
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vestibular schwannoma

Interventions

Group A:0.2mg/kg esketamine
Group B:normal saline

Sponsors

The Eye & ENT Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 to 65 years undergoing elective surgery for acoustic neuroma.

Exclusion criteria

Exclusion criteria: 1. Refuse to participate in the study; 2. Allergic to research drugs, with mental illness; 3. Inability to understand VAS scores.

Design outcomes

Primary

MeasureTime frame
visual analogue score for 24 hours activity;—

Secondary

MeasureTime frame
intraoperative BIS values;hemodynamic changes;extubation time;—

Countries

China

Contacts

Public ContactShen Xia

The Eye & ENT Hospital, Fudan University

zlsx@yahoo.com+86 13611874118

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026